The Collaborative Islet Transplantation Registry Program
Page 2

The program also seeks to deeply comprehend the factors that contribute to the success and/or failure of islet transplantation protocols and more importantly, to develop approaches for continued improvements that could essentially result in sustained graft function and therapeutic durability.

The National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases are willing to administer funds in the amount $2,650,000 to support the initiatives of the program.

The institutions and organizations who will be considered eligible to participate in this program are the following:

a) State Governments

b) County Governments

c) City or Township Govenments

d) Special District Governments

e) Independent School Districts

f) Public and State Controlled Institutions of Higher Education

g) Native American Tribal Governments

h) Public Housing Authorities/Indian Housing Authorities

i) Native American Tribal Organizations (other than Federally recognized tribal governments)

j) Nonprofit Organizations

k) Private Institutions of Higher Education

l) For-profit organizations other than small businesses

m) Small Businesses

The United States Department of Health and Human Services, the mother agency funding the The Collaborative Islet Transplantation Registry Program, is the country's leading program that's constantly working towards protecting the health of all Americans and providing fundamental human services to all.

The Collaborative Islet Transplantation Registry Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

International Research Collaboration on Drug Abuse and Addiction
The National Institutes of Health, in collaboration with the National Institute on Drug Abuse (NIDA), has recently established the International Research Collaboration on Drug Abuse and Addiction Program wherein they seek to solicit collaborative research applications regarding addiction and drug use, through the utilization of special opportunities and resources that exist outside the United States of America.

---

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---